Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' CLAVEY V' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 27 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chinetti, G; Lestavel, S; Bocher, V; Remaley, AT; Neve, B; Torra, IP; Teissier, E; Minnich, A; Jaye, M; Duverger, N; Brewer, HB; Fruchart, JC; Clavey, V; Staels, B
      PPAR-alpha and PPAR-gamma activators induce cholesterol removal from humanmacrophage foam cells through stimulation of the ABCA1 pathway

      NATURE MEDICINE
    2. Lestavel, S; Chinetti, G; Bocher, V; Fruchart, JC; Clavey, V; Staels, B
      Peroxisome proliferator-activated receptors in human atherosclerosis

      M S-MEDECINE SCIENCES
    3. Slimane, MN; Lestavel, S; Sun, XM; Maatouk, F; Soutar, AK; Ben Farhat, MH; Clavey, V; Benlian, P; Hammami, M
      Fh-Souassi: a founder frameshift mutation in exon 10 of the LDL-receptor gene, associated with a mild phenotype in Tunisian families

      ATHEROSCLEROSIS
    4. Junquero, D; Pilon, A; Carilla-Durand, E; Patoiseau, JF; Tarayre, JP; Torpier, G; Staels, B; Fruchart, JC; Colpaert, FC; Clavey, V; Delhon, A
      Lack of toxic effects of F 12511, a novel potent inhibitor of acylcoenzymeA: cholesterol O-acyltransferase, on human adrenocortical cells in culture

      BIOCHEMICAL PHARMACOLOGY
    5. Pilon, A; Briand, O; Lestavel, S; Copin, C; Majd, Z; Fruchart, JC; Castro, G; Clavey, V
      Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    6. Clavey, V; Copin, C; Mariotte, MC; Bauge, E; Chinetti, G; Fruchart, J; Fruchart, JC; Dallongeville, J; Staels, B
      Gels culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells

      CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
    7. Martin, G; Pilon, A; Albert, C; Valle, M; Hum, DW; Fruchart, JC; Najib, J; Clavey, V; Staels, B
      Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    8. Nion, S; Demoor, L; Boutillon, C; Luchoomun, J; Vanloo, B; Fievet, C; Castro, G; Rosseneu, M; Fruchart, JC; Tartar, A; Clavey, V
      Branched synthetic peptide constructs mimic cellular binding and efflux ofapolipoprotein AI in reconstituted high density lipoproteins

      ATHEROSCLEROSIS
    9. NISSEN H; LESTAVEL S; HANSEN TS; LUC G; BRUCKERT E; CLAVEY V
      MUTATION SCREENING OF THE LDLR GENE AND APO-B GENE IN PATIENTS WITH APHENOTYPE OF FAMILIAL HYPERCHOLESTEROLEMIA AND NORMAL VALUES IN A FUNCTIONAL LDL RECEPTOR APOLIPOPROTEIN-B ASSAY

      Clinical genetics
    10. IGAU B; CASTRO G; CLAVEY V; SLOMIANNY C; BRESSON R; DROUIN P; FRUCHART JC; FIEVET C
      IN-VIVO GLUCOSYLATED LPA-I SUBFRACTION - EVIDENCE FOR STRUCTURAL AND FUNCTIONAL ALTERATIONS

      Arteriosclerosis, thrombosis, and vascular biology
    11. NION S; BRIAND O; LESTAVEL S; TORPIER G; NAZIH F; DELBART C; FRUCHART JC; CLAVEY V
      HIGH-DENSITY-LIPOPROTEIN SUBFRACTION-3 INTERACTION WITH GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS

      Biochemical journal
    12. NAZIHSANDERSON F; LESTAVEL S; NION S; ROUY D; DENEFLE P; FRUCHART JC; CLAVEY V; DELBART C
      HDL3 BINDS TO GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS TO ACTIVATE SIGNALING PATHWAYS

      Biochimica et biophysica acta. Molecular cell research
    13. NISSEN H; LESTAVEL S; HANSEN TS; LUC G; BRUCKERT E; CLAVEY V
      MUTATION SCREENING IN PATIENTS WITH A PHENOTYPE OF FAMILIAL HYPERCHOLESTEROLEMIA AND NORMAL VALUES IN A FUNCTIONAL LDL RECEPTOR APOLIPOPROTEIN-B ASSAY

      Atherosclerosis
    14. MARTIN G; PILON A; ALBERT C; VALLE M; HUM DW; FRUCHART JC; AUWERX J; CLAVEY V; STAELS B
      HDL (HIGH-DENSITY-LIPOPROTEIN) AND LDL (LOW-DENSITY-LIPOPROTEIN) RECEPTORS REGULATION IN HUMAN ADRENAL-CORTEX

      Atherosclerosis
    15. LESTAVEL S; BRIAND O; NION S; TORPIER G; COPIN C; FRUCHART JC; CLAVEY V
      CAVEOLAE AND GLYCOSYL PHOSPHATIDYLINOSITOL-ANCHORED PROTEINS - A SPECIFIC BINDING MEMBRANE DOMAIN FOR HIGH-DENSITY-LIPOPROTEINS

      Atherosclerosis
    16. HUGUE V; LESTAVEL S; KANDOUSSI M; DRACON M; FRUCHART JC; CLAVEY V; CACHERA C
      IN-VITRO CATABOLISM OF LP(A) FROM HEMODIALYSIS-PATIENTS BY FIBROBLASTS

      Journal of the American Society of Nephrology
    17. IGAU B; LESTAVEL S; CLAVEY V; SLOMIANNY C; DROUIN P; BRESSON R; FRUCHART JC; DURIEZ P; FIEVET C
      APO B-CONTAINING LIPOPROTEIN PARTICLES IN POORLY CONTROLLED INSULIN-DEPENDENT DIABETES

      Atherosclerosis
    18. CLAVEY V; LESTAVELDELATTRE S; COPIN C; BARD JM; FRUCHART JC
      MODULATION OF LIPOPROTEIN B BINDING TO THE LDL RECEPTOR BY EXOGENOUS LIPIDS AND APOLIPOPROTEIN-CI, APOLIPOPROTEIN-CII, APOLIPOPROTEIN-CIII,AND APOLIPOPROTEIN-E

      Arteriosclerosis, thrombosis, and vascular biology
    19. SEGEV H; RESHEF A; CLAVEY V; DELBART C; ROUTIER G; LEITERSDORF E
      PREMATURE TERMINATION CODON AT THE STEROL 27-HYDROXYLASE GENE CAUSES CEREBROTENDINOUS XANTHOMATOSIS IN A FRENCH FAMILY

      Human genetics
    20. HARDUIN P; TAILLEUX A; LESTAVEL S; CLAVEY V; FRUCHART JC; FIEVET C
      IMMUNOLOGICAL AND FUNCTIONAL-PROPERTIES OF IN-VITRO OXIDIZED LOW-DENSITY-LIPOPROTEIN

      Journal of lipid research
    21. AGUIE GA; RADER DJ; CLAVEY V; TRABER MG; TORPIER G; KAYDEN HJ; FRUCHART JC; BREWER HB; CASTRO G
      LIPOPROTEINS CONTAINING APOLIPOPROTEIN-B ISOLATED FROM PATIENTS WITH ABETALIPOPROTEINEMIA AND HOMOZYGOUS HYPOBETALIPOPROTEINEMIA - IDENTIFICATION AND CHARACTERIZATION

      Atherosclerosis
    22. GOTTRAND F; CLAVEY V; FRUCHART JC; FARRIAUX JP
      LIPOPROTEIN PATTERN AND PLASMA LECITHIN-CHOLESTEROL ACYL TRANSFERASE-ACTIVITY IN CHILDREN WITH ALAGILLE SYNDROME

      Atherosclerosis
    23. MEDIENE S; HAKEM S; BARD JM; MEDJAOUI I; BENHAMAMOUCH S; LEBEL P; FRUCHART JC; CLAVEY V
      SERUM-LIPOPROTEIN PROFILE IN ALGERIAN PATIENTS WITH CELIAC-DISEASE

      Clinica chimica acta
    24. NAZIH F; NION S; PINCHON G; LESTAVEL S; FRUCHART JC; CLAVEY V; DELBART C
      HDL(3) AND A GLYCOSYL-PHOSPHATIDYLINOSITOL ANCHORED PROTEIN ARE NECESSARY TO PROMOTE THE EARLY PHASE IN 1,2-DAG SIGNALING PATHWAY IN HEPG2 CELLS

      Circulation
    25. LESTAVELDELATTRE S; BENHAMAMOUCH S; AGNANI G; LUC G; BARD JM; BROUSSEAU T; BILLARDON C; KUSNIERZ JP; DEGENNES JL; FRUCHART JC; CLAVEY V
      EVIDENCE OF NON-DEFICIENT LOW-DENSITY-LIPOPROTEIN RECEPTOR PATIENTS IN A POOL OF SUBJECTS WITH CLINICAL FAMILIAL HYPERCHOLESTEROLEMIA PROFILE

      Metabolism, clinical and experimental
    26. LUCHOOMUN J; THERET N; CLAVEY V; DUCHATEAU P; ROSSENEU M; BRASSEUR R; DENEFLE P; FRUCHART JC; CASTRO GR
      STRUCTURAL DOMAIN OF APOLIPOPROTEIN-A-I INVOLVED IN ITS INTERACTION WITH CELLS

      Biochimica et biophysica acta, L. Lipids and lipid metabolism
    27. BROUSSEAU T; CLAVEY V; BARD JM; FRUCHART JC
      SEQUENTIAL ULTRACENTRIFUGATION MICROMETHOD FOR SEPARATION OF SERUM-LIPOPROTEINS AND ASSAYS OF LIPIDS, APOLIPOPROTEINS, AND LIPOPROTEIN PARTICLES

      Clinical chemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 08/08/20 alle ore 18:21:40